Guardant Health, Inc, a leading precision oncology company, announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX),...
Theralink Technologies, Inc, a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, announced that it has acquired an exclusive...
Corbus Pharmaceuticals Holdings, Inc, a precision oncology company, announced that it has entered into an exclusive licensing agreement with CSPC Megalith Biopharmaceutical Co., Ltd,...
